Four regions of allelic imbalance on 17q12-qter associated with high- grade breast tumors

Genes Chromosomes and Cancer

Volumn 20, Issue 4, 1997, Pages 354-362

  Plummer, Sarah J ^a   Paris, Mark J ^a   Myles, Jonathan ^a   Tubbs, Raymond ^a   Crowe, Joseph ^a   Casey, Graham ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ALLELE; ARTICLE; BREAST TUMOR; CELL CYCLE S PHASE; CHROMOSOME 17Q; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TANDEM REPEAT;

ALLELES; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0030697359     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199712)20:4<354::AID-GCC6>3.0.CO;2-0     Document Type: Article

References (58)

1. Allred DS, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL (1993) Association of TP53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200-206.
2. American Cancer Society (1996) Cancer Facts and Figures - 1996.
3. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, Borresen A-L (1992) Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer 4:113-121.
4. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Borresen A-L (1993) Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 68:540-548.
5. Bach B, Knape W, Edinger M, Tubbs R (1991) Improved sensitivity and resolution in the flow cytometric DNA analysis of human solid tumor specimens. Use of in vitro fine-needle aspiration and uniform staining reagents. Am J Clin Pathol 96:615-627.
6. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS (1989) Association of low NM23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metabolic potential. Cancer Res 49:5185-5190.
7. Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Stanbridge EJ (1993) Functional evidence for a breast cancer growth suppressor gene on chromosome 17. Human Mol Genet 2:1921-1927.
8. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B, Slamon (1996) DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogcne 13:1971-1981.
9. Clark GM (1996) Prognostic and predictive factors. In Harris JR, Lippman ME, Morrow M, Hellman S (eds): Diseases of the Breast. Philadelphia, Lippincott-Raven, pp 461-485.
10. Cornelis RS, Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Kersenmaeker A, Bardoel A, Khan PM, Cornelisse CJ (1993) Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions. Oncogene 8:781-785.
11. Cropp CS, Champeme M-H, Lidereau R, Callahan R (1993) Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53:5617-5619.
12. Cropp CS, Lidereau R, Leone A, Liscia D, Cappa AP, Campbell G, Barker E, Le Doussal V, Steeg PS, Callahan R (1994) NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors. J Natl Cancer Inst 86:1167-1169.
13. Devilee P, Van Vliet M, Bardoel A, Kievits T, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ (1991) Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51:1020-1025.
14. Devilee P, Cornelisse CJ (1994) Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198:113-130.
15. Devilee P, Hermans J, Eyfjord J, Borresen A-L, Lidereau R, Sobol H, Borg A, Cleton-Jansen A-M, Olah E, Cohen BB, Scherneck S, Hamann U, Peterlin B, Caligo M, Bignon Y-J, Maugard Ch, The Breast Cancer Somatic Genetics Consortium (1997) Loss of heterozygosity at 7q31 in breast cancer: results from an international collaborative study group. Genes Chromosomes Cancer 18:193-199.
16. Dib C, Faure S, Fizames C, Samsom D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
17. Futreal PA, Söderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW (1992) Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52:2624-2627.
18. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R (1494) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
19. Goelz S, Hamilton S, Vogelstein B (1985) Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 130:118-126.
20. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
21. Gruis NA, Abeln ECA, Bardoel AFJ, Devilee P, Frants RR, Cornelisse CJ (1993) PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. Br J Cancer 68:308-313.
22. Guan X-Y, Meltzer PS, Dalton WS, Trent JM (1994) Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet 8:155-161.
23. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994) The 1993-1994 Genethon human genetic linkage map. Nat Genet 7:246-249.
24. Hedley D, Clark G, Cornelisse C, Killander D, Kute T, Merkel D (1993) DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Breast Cancer Res Treatment 28:55-59.
25. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53.
26. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silba J, Slonim DK, Baptista R, Kruglyak L, Xu S, Hu X, Colbert AM, Rosenberg C, Reeve-Daly MP, Rozen S, Hui K, Wu X, Vestergaard C, Wilson KM, Bae JS, Maitra S, Ganiatsas S, Evans CA, DeAngelis MM, Ingalls KA, Nahf RW, Horton Jr LT, Anderson MO, Collymore AJ, Ye W, Kouyoumjian V, Zemsteva IS, Tam J, Devine R, Courtney DF, Renaud MR, Nguyen H, O'Connor TJ, Fizames C, Faure S, Gyapay G, Dib C, Morissette J, Orlin JB, Birren BW, Goodman N, Weissenbach J, Havvkins TL, Foote S, Page DC, Lander ES (1995) An STS-based map of the human genome. Science 270: 1945-1954.
27. Ito I, Yoshimoto M, Iwase T, Watanabw S, Katagiri T, Harada Y, Kasumi F, Yasuda S, Mitomi T, Emi M, Nakamura Y (1995) Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer 71:438-41.
28. Kalikin LM, Qu X, Frank TS, Caduff RF, Svoboda SM, Law DJ, Petty EM (1996) Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25. Genes Chromosomes Cancer 17:64-68.
29. Kalikin LM, Frank TS, Svoboda-Newman SM, Wetzel JC, Cooney KA, Petty EM (1997) A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors. Oncogene 14:1991-1994.
30. Kallioniemi A, Kallioniemi O-P Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
31. Kirchweger R, Zeillinger R, Schneeberger C, Speiser P, Louason G, Theillet C (1994) Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Intl J Cancer 56:193-199.
32. Lagios M (1990) Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 70:853-871.
33. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M (1989) Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64:1914-1921.
34. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B (1994) Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer 10:160-170.
35. Munn K, Walker R, Menasce L, Varley J (1996) Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast. Br J Cancer 73:636-639.
36. Murakami YS, Brothman AR, Leach RJ, White RL (1995) Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 55:3389-3394.
37. Murphy D, Hoare S, Going J, Mallon E, George W, Kaye S, Brown R, Black D, Keith W (1995) Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst 87:1694-1704.
38. Nagai MA, Yamamoto L, Salaorni S, Pacheco MM, Brentani MM, Barbosa EM, Brentani RR, Mazoyer S, Smith SA, Ponder BAJ, Mulligan LM (1994) Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer 11:58-62.
39. Nagai MA, Medeiros AC, Brentani MM, Brentani RR, Marques LA, Mazoyer S, Mulligan LM (1995) Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology 52:448-453.
40. Negrini M, Sabbioni S, Haldar S, Possati L, Castagnoli A, Corallini A, Barbanti-Brodano G, Croce CM (1994) Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res 54:1818-1824.
41. Niederacher D, Picard F, van Roeyen C, An HX, Bender HG, Beckmann MW (1997) Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer 18:181-192.
42. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S (1995) Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12:173-185.
43. Plummer SJ, Adams L, Simmons JA, Casey G (1997) Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25. Oncogene 14:2339-2345.
44. Plummer SJ, Simmons JA, Adams L, Casey G Mapping of 228 ESTs and 26 genes into an integrated physical and genetic map of chromosome 17. Genomics (in press).
45. Ponten J, Holmberg L, Trichopoulos D, Kallioniemi O, Kvale G, Wallgren A, Taylor-Papadimitriou J (1990) Biology and natural history of breast cancer. International Journal of Cancer 5:5-21.
46. Radford DM, Fair KL, Philips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H (1995) Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 55:3399-3405.
47. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, Ichikawa T, Barrett JC, Isaacs JT (1994) Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 54:6249-6256.
48. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP (1990) p55 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559.
49. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y (1941) Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51:5744-5799.
50. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U (1993) p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965-970.
51. Simpson H, Candlish W, Pauson A, McArdle C, Griffiths K, Small R (1988) Genesis of breast cancer is in the premenopause. Lancet 2:74-76.
52. Slamon DJ, Godophin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
53. Stack M, Jones D, White G, Liscia DS, Venesio T, Casey G, Crichton D, Varley J, Mitchell E, Heighway J, Santibanez-Koref M (1995) Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Human Mol Genet 4:2047-2055.
54. Theile M, Hartmann S, Scherthan H, Arnold W, Deppert W, Frege R, Glaab F, Haensch W, Schernech S (1995) Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene 10:439-447.
55. Thompson F, Emerson J, Dalton W, Yang JM, McGee D, Villar H, Knox S, Massey K, Weinstein R, Bhattacharyya A, Trent J (1993) Clonal chromosome abnormalities in human breast carcinomas. I. Twenty-eight cases with primary disease. Genes Chromosomes Cancer 7:185-193.
56. Thor AD, Moore II DH, Edgerton SM, Kawasaki ES, Reihsaua E, Lynch HT, Marcus JN, Schwartz L, Chen L-C, Mayall BH, Smith HS (1992) Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845-855.
57. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H (1993) Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 55:65-71.
58. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Juerbitz SJ, Baylin SB (1995) p53 activates expression of H1C-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med 1:570-577.